Position
BRAIDWELL LP in Biomarin Pharmaceutical Inc
Back to the book · All holders of BMRN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.46M$59.43 → $56.49
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 601.5K | $35.7M | — | — | — | 1.1% |
| Q1 2026 | 497K | $28.1M | $56.49 | −$1.46M | −$6.21M | 0.9% |